Desq Long
Sign in
SEC FORM 4
—

Eton Pharmaceuticals, Inc. (ETON)

Acquisition (code M) of 10,522 shares; price not stated (see filing).

Reporting Person Krempa David · Officer Title Chief Business Officer · Transaction Code M

Traded Oct 2, 2026 · Disclosed Oct 6, 2026

Source: SEC Form 4 · 0001437749-26-032240 · filed 2026-10-06 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Eton Pharmaceuticals, Inc. (ETON)." Disclosed 2026-10-06. https://desqlong.com/cards/0001437749-26-032240-1 (retrieved 2026-10-07).